10.05.2022 Ecraid introduces new COO Nils Visser Utrecht, 10 May 2022 – The Ecraid Management Board is pleased to announce the appointment of Nils Visser as its new Chief Operat…
9.05.2022 Developing sustainable solutions to fight COVID-19 and COVID-like illness The ECRAID-Prime study is the first-of-its-kind multi-country, adaptive platform trial in primary care across Europe.
29.04.2022 Ecraid brought insights and expertise to ECCMID 2022 Highlights from Ecraid's first appearance at ECCMID.
2.03.2022 Our coordinating committee on Ecraid We spoke to some of our Coordinating Committee members about what Ecraid means for the future of clinical trials and what they'r…
